{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T15:18:26Z","timestamp":1776784706204,"version":"3.51.2"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"27","license":[{"start":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T00:00:00Z","timestamp":1688688000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,7,7]]},"abstract":"<jats:sec>\n            <jats:title>Introduction:<\/jats:title>\n            <jats:p>Advanced age is one of the primary risk factors for infertility. Poor ovarian response (POR) to exogenous gonadotropin is a prominent characteristic of advanced-age women undergoing in vitro fertilization and embryo transfer (IVF-ET), which results in fewer retrieved oocytes and poor pregnancy outcomes. Traditional Chinese medicine (TCM) has been shown to improve female fertility. Erzhi Tiangui (EZTG) formula, in the form of granules with 10 herbal ingredients, demonstrated potential benefits in improving oocyte and embryo quality and ovarian reserve. Thus, this study aims to evaluate the efficacy and safety of EZTG formula.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Method:<\/jats:title>\n            <jats:p>The study is a multicenter, double-blind, placebo-controlled, randomized controlled trial (RCT), which will be conducted at 10 reproductive centers of tertiary hospitals. This study will enroll 480 women with expected POR of advanced age (\u226535 years old) who fulfill the 2011 Bologna criteria. Participants will be assigned to either the EZTG group or the placebo group at random in an equal ratio. Each individual will receive conventional IVF-ET with EZTG granules or placebo as a complementary treatment. The primary outcome is the number of oocytes retrieved. Adverse events and safety assessments will be also conducted.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Discussion:<\/jats:title>\n            <jats:p>This study aims to provide robust evidence of the efficacy and safety of EZTG formula as a complementary treatment for advanced-age women with expected POR undergoing IVF-ET.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000034088","type":"journal-article","created":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T12:03:24Z","timestamp":1688731404000},"page":"e34088","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["The role of Erzhi Tiangui formula in expected poor ovarian responders undergoing in vitro fertilization-embryo transfer: A multicenter, randomized, double-blind, placebo-controlled trial"],"prefix":"10.1097","volume":"102","author":[{"given":"Qiao-Song","family":"Han","sequence":"first","affiliation":[{"name":"The First Clinical College, Shandong University of Traditional Chinese Medicine, Jinan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Zhou","sequence":"additional","affiliation":[{"name":"The College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Chen","sequence":"additional","affiliation":[{"name":"The First Clinical College, Shandong University of Traditional Chinese Medicine, Jinan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2700-017X","authenticated-orcid":false,"given":"Jing-Yan","family":"Song","sequence":"additional","affiliation":[{"name":"The First Clinical College, Shandong University of Traditional Chinese Medicine, Jinan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen-Gao","family":"Sun","sequence":"additional","affiliation":[{"name":"Reproductive Center of Integrated Medicine, The Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3389\/fendo.2019.00094","article-title":"Advanced maternal age in IVF: still a challenge? The present and the future of its treatment.","volume":"10","author":"Ubaldi","year":"2019","journal-title":"Front Endocrinol"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.rbmo.2019.12.006","article-title":"Is early initiation of infertility treatment justified in women over the age of 35 years?.","volume":"40","author":"Somigliana","year":"2020","journal-title":"Reprod Biomed Online"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/humrep\/dem431","article-title":"Effect of female age on the diagnostic categories of infertility.","volume":"23","author":"Maheshwari","year":"2008","journal-title":"Hum Reprod"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1093\/humrep\/der092","article-title":"ESHRE consensus on the definition of \u201cpoor response\u201d to ovarian stimulation for in vitro fertilization: the Bologna criteria.","volume":"26","author":"Ferraretti","year":"2011","journal-title":"Hum Reprod"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.rbmo.2018.01.008","article-title":"Poor ovarian response as a predictor for live birth in older women undergoing IVF.","volume":"36","author":"Cohen","year":"2018","journal-title":"Reprod Biomed Online"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10815-007-9187-9","article-title":"The clinical analysis of poor ovarian response in in-vitro-fertilization embryo-transfer among Chinese couples.","volume":"25","author":"Zhen","year":"2008","journal-title":"J Assist Reprod Genet"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.tjog.2019.01.006","article-title":"Cumulative live birth rate of advanced-age women more than 40 with or without poor ovarian response.","volume":"58","author":"Yin","year":"2019","journal-title":"Taiwan J Obstet Gynecol"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"800","DOI":"10.3389\/fendo.2019.00800","article-title":"Dehydroepiandrosterone supplementation improves the outcomes of in vitro fertilization cycles in older patients with diminished ovarian reserve.","volume":"10","author":"Chen","year":"2019","journal-title":"Front Endocrinol"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1093\/humrep\/deac081","article-title":"Estrogen valerate pretreatment with the antagonist protocol does not increase oocyte retrieval in patients with low ovarian response: a randomized controlled trial.","volume":"37","author":"Zhang","year":"2022","journal-title":"Hum Reprod"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"1072313","DOI":"10.3389\/fendo.2022.1072313","article-title":"Regulation of ovarian function by growth hormone: potential intervention of ovarian aging.","volume":"13","author":"Han","year":"2023","journal-title":"Front Endocrinol"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12958-018-0342-1","article-title":"Individualized controlled ovarian stimulation in expected poor-responders: an update.","volume":"16","author":"Haahr","year":"2018","journal-title":"Reprod Biol Endocrinol"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s11655-020-3484-x","article-title":"Effects of Bushen Yiqi Huoxue Decoction in treatment of patients with diminished ovarian reserve: a randomized controlled trial.","volume":"28","author":"Zhou","year":"2022","journal-title":"Chin J Integr Med"},{"key":"R13-20250504","first-page":"343","article-title":"Effectiveness of tonifying-kidney and regulating-liver therapy on diminished ovarian reserve: a systematic review and Meta-analysis of randomized controlled trials.","volume":"40","author":"Liu","year":"2020","journal-title":"J Tradit Chin Med"},{"key":"R14-20250504","first-page":"3165","article-title":"Sequential therapy for kidney-tonifying via traditional Chinese medicine effectively improves the reproductive potential and quality of life of women with decreased ovarian reserve: a randomized controlled study.","volume":"13","author":"Duan","year":"2021","journal-title":"Am J Transl Res"},{"key":"R15-20250504","first-page":"1315","article-title":"Effect of Erzhi Tiangui Decoction on granulosa cells apoptosis in lVF-ET patients with Shen-qi deficiency.","volume":"37","author":"Lian","year":"2017","journal-title":"Chin J Integr Tradit West Med"},{"key":"R16-20250504","first-page":"540","article-title":"Impact of Erzhi Tiangui Granule on expression of key proteins of Fas channel in granulosa cells.","volume":"44","author":"Li","year":"2017","journal-title":"Liaoning J Tradit Chin Med"},{"key":"R17-20250504","first-page":"171","article-title":"Effects of Erzhi Tiangui Granule on Mfn2 of advanced maternal age IVF-ET patients with Shen Qi and Yin deficiency.","volume":"40","author":"Lian","year":"2020","journal-title":"Chin J Integr Tradit West Med"},{"key":"R18-20250504","first-page":"1","article-title":"Erzhi Tiangui Granules improve in vitro fertilization outcomes in infertile women with advanced age.","volume":"2021","author":"Sun","year":"2021","journal-title":"Evid Based Complement Alternat Med"},{"key":"R19-20250504","first-page":"13","article-title":"Effects of Er-zhi Tian-gui granule on expression of GDNF, GFR-l in granulosa cell of superovulation cycle.","volume":"20","author":"Chen","year":"2019","journal-title":"J Shanxi Univ Chin Med"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.joim.2022.02.004","article-title":"Improving the health and treatment success rates of in vitro fertilization patients with traditional Chinese medicine: need for more robust evidence and innovative approaches.","volume":"20","author":"Casale","year":"2022","journal-title":"J Integr Med"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"102528","DOI":"10.1016\/j.ctim.2020.102528","article-title":"Herbal medicine in women undergoing in vitro fertilization\/ intracytoplasmic sperm injection: a systematic review and meta-analysis.","volume":"53","author":"Kwon","year":"2020","journal-title":"Complement Ther Med"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"e7586","DOI":"10.1136\/bmj.e7586","article-title":"SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials.","volume":"346","author":"Chan","year":"2013","journal-title":"BMJ"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"642","DOI":"10.3389\/fendo.2019.00642","article-title":"Cumulative live birth rates in low prognosis patients according to the POSEIDON criteria: an analysis of 26,697 cycles of in vitro fertilization\/intracytoplasmic sperm injection.","volume":"10","author":"Li","year":"2019","journal-title":"Front Endocrinol"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.3390\/ijms23052880","article-title":"Chromosome segregation in the oocyte: what goes wrong during aging.","volume":"23","author":"Wasielak-Politowska","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"102307","DOI":"10.1016\/j.bpobgyn.2022.102307","article-title":"Association between the number of oocytes and cumulative live birth rate: a systematic review.","volume":"87","author":"Neves","year":"2023","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1007\/s10815-019-01446-5","article-title":"Apoptosis of mural granulosa cells is increased in women with diminished ovarian reserve.","volume":"36","author":"Fan","year":"2019","journal-title":"J Assist Reprod Genet"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1002\/cbin.11036","article-title":"Clinical correlation of apoptosis in human granulosa cells-a review: apoptosis in human granulosa cells.","volume":"42","author":"Almeida","year":"2018","journal-title":"Cell Biol Int"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1016\/j.fertnstert.2009.09.047","article-title":"Glial cell line\u2013derived neurotrophic factor (GDNF) and its receptors in human ovaries from fetuses, girls, and women.","volume":"93","author":"Farhi","year":"2010","journal-title":"Fertil Steril"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/humupd\/dmy047","article-title":"Neurotrophins and glial cell line-derived neurotrophic factor in the ovary: physiological and pathophysiological implications.","volume":"25","author":"Chang","year":"2019","journal-title":"Hum Reprod Update"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000034088","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T02:02:14Z","timestamp":1746324134000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000034088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,7]]},"references-count":29,"journal-issue":{"issue":"27","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000034088","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7,7]]}}}